Print

IAVI 006

A dual centre, randomised, Phase I study to evaluate the safety and immunogenicity of 2 doses of candidate HIV-1 clade A DNA vaccine or placebo followed by a candidate HIV-1 clade A MVA vaccine or placebo in healthy volunteers at low risk of HIV infection

Trial Details:

I/II Completed
Medical Research Council (MRC)/Oxford April 04, 2002
DNA.HIVA ,MVA.HIVA Pox Gag A; DNA Gag A
DNA.HIVA DNA
MVA.HIVA Viral Vector - Pox
United Kingdom 120
http://www.iavi.org